Medicare and insurance
Medicare drug price negotiation explained
For decades, Medicare was not allowed to negotiate drug prices directly with manufacturers. The Inflation Reduction Act of 2022 changed that. Medicare now negotiates prices for a growing list of high-cost drugs, and the first negotiated prices took effect on January 1, 2026. This guide explains how the program works, which drugs are included, and - importantly - how it may or may not change what you pay.
Key takeaways
- Medicare's first 10 negotiated prices took effect on January 1, 2026, for Part D drugs.
- Fifteen more drugs, including Ozempic, Rybelsus and Wegovy, get negotiated prices from January 1, 2027.
- Fifteen drugs were selected in January 2026 for prices starting in 2028, including the first Part B drugs.
- Negotiated prices are often far below list prices - for example, Eliquis went from $521 to $231 for a 30-day supply.
- Your own savings depend on your plan's copays and coinsurance, not just the lower price.
- Separately, the Part D out-of-pocket cap is $2,100 in 2026.
How negotiation works
Each year, the Centers for Medicare & Medicaid Services (CMS) selects drugs that account for high Medicare spending and that have been on the market for several years without generic or biosimilar competition. CMS then negotiates with each manufacturer over a period of months. The outcome is a "maximum fair price" that Medicare plans and pharmacies use for people with Medicare.
The program has grown in stages:
- 2026: 10 Part D drugs (prescriptions you fill at a pharmacy).
- 2027: 15 more Part D drugs.
- 2028: 15 more drugs, now including Part B drugs (typically given in a doctor's office or clinic).
Negotiated prices apply to Medicare. They do not apply to commercial insurance or to people paying cash, although they may influence prices elsewhere over time.
The first 10 drugs (prices effective January 1, 2026)
- Eliquis
- Jardiance
- Xarelto
- Januvia
- Farxiga
- Entresto
- Enbrel
- Imbruvica
- Stelara
- NovoLog / Fiasp
The next 15 drugs (prices effective January 1, 2027)
- Ozempic / Rybelsus / Wegovy
- Trelegy Ellipta
- Xtandi
- Pomalyst
- Ofev
- Ibrance
- Linzess
- Calquence
- Austedo / Austedo XR
- Breo Ellipta
- Xifaxan
- Vraylar
- Tradjenta
- Janumet / Janumet XR
- Otezla
Drugs selected for 2028
In January 2026, CMS selected 15 more drugs for negotiation, with prices taking effect in 2028. This is the first group to include Part B drugs:
- Trulicity
- Biktarvy
- Orencia
- Cosentyx
- Erleada
- Kisqali
- Entyvio
- Verzenio
- Botox
- Lenvima
- Xolair
- Rexulti
- Xeljanz
- Anoro Ellipta
- Cimzia
Negotiations for this group run during 2026, and the resulting prices are due to be published ahead of 2028.
Example prices
CMS publishes each negotiated price alongside the drug's list price. A few examples, for a 30-day supply:
| Drug | List price | Negotiated price | Takes effect |
|---|---|---|---|
| Eliquis | $521 | $231 | January 1, 2026 |
| Januvia | $527 | $113 | January 1, 2026 |
| Ozempic / Rybelsus / Wegovy | $959 | $274 | January 1, 2027 |
| Trelegy Ellipta | $654 | $175 | January 1, 2027 |
You can see the negotiated prices on our Medicare drug prices page, and on drug pages such as Eliquis and Ozempic.
What it means for what you pay
A big drop in the negotiated price does not automatically mean the same drop in your costs. What you pay depends on how your Part D plan charges for the drug:
- Flat copay. If your plan charges a fixed copay - say a set amount per month - that copay may stay the same even though the drug's price fell.
- Coinsurance. If you pay a percentage of the drug's price, a lower price generally means a lower payment.
- Deductible. If you are in your plan's deductible and paying the full price, a lower negotiated price may reduce what you pay before coverage starts.
- Out-of-pocket cap. Lower prices may mean you reach the annual cap later, or not at all, depending on your other medicines.
Plans can also change their formularies, tiers and premiums from year to year. The best way to know your own costs is to check your plan's drug list and cost details, or use Medicare's plan comparison tools during open enrollment.
The Part D out-of-pocket cap
Alongside negotiation, the Inflation Reduction Act redesigned Part D cost-sharing. Since 2025, there has been an annual cap on what you pay out of pocket for covered Part D drugs. In 2026 the cap is $2,100. Once you reach it, you pay nothing more for covered Part D drugs for the rest of the year. The cap is adjusted each year.
Medicare also offers the Medicare Prescription Payment Plan, which lets you spread out-of-pocket costs across monthly payments rather than paying large amounts at the pharmacy. And insulin covered by Part D has been capped at $35 for a month's supply since 2023 - see insulin prices explained.
If you pay for a Part D drug outside your plan, such as with a discount card, the cost generally does not count toward the cap. See prescription discount cards explained.
How to check your costs
- Find out whether your drug is on the negotiated list using our Medicare drug prices page.
- Check your plan's formulary to see the drug's tier and whether you pay a copay or coinsurance.
- Ask your plan or pharmacist what you will pay per fill under the negotiated price.
- Estimate your yearly out-of-pocket costs for all your medicines and compare with the cap.
- During open enrollment, compare plans based on the specific drugs you take.
- If costs are still hard to manage, ask about Extra Help, the Medicare Prescription Payment Plan, or a lower-cost alternative your prescriber considers suitable.
Beyond Medicare
If you are not on Medicare, negotiated prices will not apply to your prescriptions directly. You can still compare your price with what pharmacies pay and with a fair cash price.
Free toolIs my drug price fair? Check any quoteFor the bigger picture on how drug prices are set, read why are drug prices so expensive. If you are on Medicare and have filled one of the negotiated drugs, you can share what you paid to help others see how the changes are working at the counter.
This guide is general information, not medical or financial advice. Talk to your pharmacist or prescriber about your own medicines.
Questions about this guide
No comments yet. Questions, tips, what worked for you - start the conversation.